Volume 3, Issue 1 (March 2017)                   Curr Med Mycol 2017, 3(1): 20-24 | Back to browse issues page

XML Print

Abstract:   (519 Views)
Background and Purpose: The epidemiological features of dermatophytoses have been characterized in many geographical locations of Iran, but not in Guilan, North of Iran. This study was carried out to determine the distribution pattern of dermatophytoses and their relevant agents in Guilan, North of Iran, over a period of one year, from April 2010 to April 2011.
Materials and Methods: The clinical samples of skin, hair, and nail from 889 outpatients (317 men vs. 572 women) were used for direct microscopy and culture. All the culture-positive samples were then subjected to amplification of the internal transcribed spacer (ITS) of the nuclear rDNA followed by a restriction fragment length polymorphism (RFLP) assay to verify the causative agents.
Results: The infection was confirmed in 90 (44.3%) males and 113 (55.7%) females.The most common type of dermatophytoses was tinea cruris (42.9%), followed by tinea pedis (20.2%), tinea corporis (11.3%), tinea unguium (7.4%), tinea faciei (6.9%), tinea manuum (6.4%), and tinea capitis (4.9%). ITS-RFLP based of the identification of isolates, showed that the infections were significantly associated with anthropophilic species, of Trichophyton rubrum (41.9%), Epidermophyton floccosum (19.7%), T.tonsurans (5.4%), and T. violaceum (2%). Other causative agents were T. interdigitale (22.6%),Microsporum canis (4.9%), T. verrucosum (2.5%), and M. gypseum. (1%).
Conclusion: The higher prevalence of T. rubrum, as the agent of dermatophytoses, than other species has never been reported from Iran and is of public health concern because of the chronic nature of infections with anthropophilic species. To thoroughly investigate the epidemiological trend of dermatophytoses in Iran, further periodical and molecularbased studies are necessary.
Full-Text [PDF 718 kb]   (232 Downloads)    
Type of Study: Original Articles | Subject: Epidemiology
Received: 2017/09/5 | Accepted: 2017/10/16 | Published: 2017/12/13

1. Padhye AA, Summerbell RC. The dermatophytes, In: Merz WG, Hay RJ. Topley and Wilson's microbiology and microbial infections: medical mycology, 10th ed. London: Arnold 2005:220-43.
2. Weitzman I, Summerbell RC. The dermatophytes. Clin Microbiol Rev 1995;8:240-59.
3. Costa-Orlandi CB, Magalhães GM, Oliveira MB, Taylor EL, Marques CR, de Resende-Stoianoff MA. Prevalence of dermatomycosis in a Brazilian tertiary care hospital. Mycopathologia. 2012;174:489-97. [DOI:10.1007/s11046-012-9576-1]
4. Ameen A. Epidemiology of superficial fungal infections. Clinics in Dermatology. 2010; 28:197-201. [DOI:10.1016/j.clindermatol.2009.12.005]
5. Neji S, Makni F, Cheikhrouhou F, et al. Epidemiology of dermatophytoses in Sfax, Tunisia. Mycoses. 2009;52:534-8. [DOI:10.1111/j.1439-0507.2008.01651.x]
6. Badali H, Mohammadi R, Mashedi O, Hoog GS, Meis JF. In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs. Mycoses. 2015;58:303-7. [DOI:10.1111/myc.12315]
7. Tamura T, Asahara M, Yamamoto M, Yamaura M, Matsumura M, Goto K, et al. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluationby fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes. Microbiol Immunol. 2014;58(1)-8.
8. Rezaei-Matehkolaei A, Mirhendi H, Makimura K, et al. Nucleotide sequence analysis of beta tubulin gene in a wide range of dermatophytes. Med Mycol. 2014;52(7):674-88. [DOI:10.1093/mmy/myu033]
9. Abastabar M, Mirhendi H, Rezaei‐Matehkolaei A, Shidfar MR, Kordbacheh P, Makimura K. Restriction analysis of β‐tubulin gene for differentiation of the common pathogenic dermatophytes. J Clin Lab Anal. 2014;28(2):91-6. [DOI:10.1002/jcla.21649]
10. Mirhendi H, Makimura K, de Hoog GS, et al. Translation elongation factor 1-alpha gene as a potential taxonomic and identification marker in dermatophytes. Medical mycology. 2015;53(3):215-24. [DOI:10.1093/mmy/myu088]
11. Abastabar M, Rezaei-Matehkolaei A, Shidfar MR, Kordbacheh P, Mohammadi R, Shokoohi T, et al. A Molecular Epidemiological Survey of Clinically Important Dermatophytes in Iran Based on Specific RFLP Profiles of Beta-tubulin Gene. Iranian journal of public health. 2013;42(9):1049-57.
12. Rezaei-Matehkolaei A, Makimura K, de Hoog S, Shidfar MR, Zaini F, Eshraghian M, et al. Molecular epidemiology of dermatophytosis in Tehran, Iran, a clinical and microbial survey. Med Mycol. 2013;51(2):203-7. [DOI:10.3109/13693786.2012.686124]
13. Mahmoudabadi AZ. A study of dermatophytosis in South West of Iran (Ahwaz). Mycopathologia. 2005;160:21-4. [DOI:10.1007/s11046-005-7458-5]
14. Chadeganipour M, Shadzi S, Dehghan P, Movahed M. Prevalence and aetiology of dermatophytoses in Isfahan, Iran. Mycoses. 1997;40:321-4. [DOI:10.1111/j.1439-0507.1997.tb00240.x]
15. Omidynia E, Farshchian M, Sadjjadi M, Zamanian A, Rashidpouraei R. A study of dermatophytoses in Hamadan, the governmentship of West Iran. Mycopathologia. 1996;133(1):9-13. [DOI:10.1007/BF00437093]
16. Aghamirian MR, Ghiasian SA. Dermatophytoses in outpatients attending the Dermatology Center of Avicenna Hospital in Qazvin, Iran. Mycoses. 2008;51(2):155-60. [DOI:10.1111/j.1439-0507.2007.01450.x]
17. Ansari S, Hedayati MT, Zomorodian K, et al. Molecular Characterization and In Vitro Antifungal Susceptibility of 316 Clinical Isolates of Dermatophytes in Iran. Mycopathologia. 2016;181(1-2):89-95. [DOI:10.1007/s11046-015-9941-y]
18. Alizadeh N, Sadr Ashkevari S, Golchai J., Maboodi A.,Falahati A. A descriptive study of dermatophytosis in Guilan. Iranian J Dermato 2004; 7 (4): 255- 60
19. White TJ, Bruns T, Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In PCR Protocols: a Guide to Methods and Applications, Edited by M. A. Innis. London: Academic Press; 1990. pp. 315-22. [DOI:10.1016/B978-0-12-372180-8.50042-1]
20. Maraki S, Nioti E, Mantadakis E, Tselentis Y. A 7-year survey of dermatophytoses in Crete, Greece. Mycoses. 2007;50(6): 481-4. [DOI:10.1111/j.1439-0507.2007.01403.x]
21. Seebacher C, Bouchara JP, Mignon B. Updates on the Epidemiology of Dermatophyte Infections. Mycopathologia. 2008;166(5-6):335-52. [DOI:10.1007/s11046-008-9100-9]
22. Kuklová I, Kucerová H. Dermatophytoses in Prague, Czech Republic, between 1987 and 1998. Mycoses. 2001;44(11-12):493-6. [DOI:10.1046/j.1439-0507.2001.00697.x]
23. Vella Zahra L, Gatt P, Boffa MJ, et al. Characteristics of superficial mycoses in Malta. Int J Dermatol. 2003;42(4):265-71. [DOI:10.1046/j.1365-4362.2003.01789.x]
24. East-Innis A, Rainford L, Dunwell P, Barrett-Robinson D, Nicholson AM. The changing pattern of Tinea capitis in Jamaica. West Indian Med J. 2006;55(2):85-8. [DOI:10.1590/S0043-31442006000200004]
25. Rezaei-Matehkolaei A, Rafiei A, Makimura K, Gräser Y, Gharghani M, Sadeghi-Nejad B. Epidemiological aspects of dermatophytosis in Khuzestan, southwestern Iran, an update. Mycopathologia. 2016;181(7-8):547-53. [DOI:10.1007/s11046-016-9990-x]
26. Aste N, Pau M, Biggio P. Tinea pedis observed in Cagliari, Italy, between 1996 and 2000. Mycoses. 2003;46(1-2):38-41. [DOI:10.1046/j.1439-0507.2003.00794.x]
27. Vena GA, Chieco P, Posa F, Garofalo A, Bosco A, Cassano N. Epidemiology of dermatophytoses: retrospective analysis from 2005 to 2010 and comparison with previous data from 1975. New Microbiol. 2012;35(2): 207-13.
28. Bassiri-Jahromi S, Khaksari AA. Epidemiological survey of dermatophytosis in Tehran, Iran, from 2000 to 2005. Indian J Dermatol Venereol Leprol. 2009;75(2):142-7. [DOI:10.4103/0378-6323.48658]
29. Nouripour-Sisakht S, Rezaei-Matehkolaei A, Abastabar M, et al. Microsporum fulvum, an Ignored Pathogenic Dermatophyte: A New Clinical Isolation from Iran. Mycopathologia. 2013;176(1-2):157-60. [DOI:10.1007/s11046-013-9665-9]
30. Rezaei-Matehkolaei A, Koichi Makimura K, Graser Y, et al. Dermatophytosis due to Microsporum incurvatum: Notification and Identification of a Neglected Pathogenic Species. Mycopathologia. 2016;181(1-2):107-113. [DOI:10.1007/s11046-015-9946-6]
31. Gupta AK. Onychomycosis in the elderly. Drugs Aging. 2000;16(6):397-407. [DOI:10.2165/00002512-200016060-00002]
32. Gill D, Marks R. A review of the epidemiology of tinea unguium in the community. Australas J Dermatol. 1999;40(1):6-13. [DOI:10.1046/j.1440-0960.1999.00308.x]
33. Nicola A, Laura A, Natalia A, Monica P. A 20-year survey of tinea faciei. Mycoses. 2010;53(6):504-508. [DOI:10.1111/j.1439-0507.2009.01748.x]
34. Lin RL, Szepietowski JC, Schwartz RA. Tinea faciei, an often deceptive facial eruption. Int J Dermatol. 2004;43(6):437-40. [DOI:10.1111/j.1365-4632.2004.02339.x]
35. Ghelardi E, Celandroni F, Gueye SA, Salvetti S, Senesi S, Bulgheroni A, Mailland F. Potential of Ergosterol synthesis inhibitors to cause resistance or cross-resistance in Trichophyton rubrum. Antimicrobial agents and chemotherapy. 2014;58(5):2825-9. [DOI:10.1128/AAC.02382-13]
36. Gräser Y, Scott J, Summerbell R.The new species concept in dermatophytes-a polyphasic approach. Mycopathologia. 2008;166(5-6):239-56. [DOI:10.1007/s11046-008-9099-y]